JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited [JAGSNPHARM.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JAGSNPHARM.NS Stock Summary

Top 10 Correlated ETFs

JAGSNPHARM.NS

Top 10 Correlated Stocks

JAGSNPHARM.NS

In the News

JAGSNPHARM.NS Financial details

Company Rating
-
Market Cap
7.73B
Income
245.16M
Revenue
2.21B
Book val./share
-
Cash/share
-
Dividend
5
Dividend %
1.26%
Employees
940
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
36.97
Forward P/E
-
PEG
12.38
P/S
4.49
P/B
6.19
P/C
-
P/FCF
80.88
Quick Ratio
5.39
Current Ratio
6.34
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
9.35
EPS next Y
-
EPS next Q
-
EPS this Y
41.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
29.97%
Revenue last 5Y
7.25%
Revenue Q/Q
-18.32%
EPS Q/Q
-47.02%
-
-
-
-
SMA20
5.26%
SMA50
5.73%
SMA100
3.9%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
35%
ROC
0.2%
Gross Margin
62%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
273.6-514.85
52W High
-50.89%
52W Low
-7.53%
RSI
66
Rel Volume
5.52
Avg Volume
42.44K
Volume
234.24K
Perf Week
9.87%
Perf Month
7.96%
Perf Quarter
10.59%
Perf Half Y
25.56%
-
-
-
-
Beta
0.991
-
-
Volatility
8.71%, 10.23%
Prev Close
2.49%
Price
252.43
Change
1.78%

JAGSNPHARM.NS Financial Performance

JAGSNPHARM.NS Dividend History

JAGSNPHARM.NS Frequently Asked Questions

What is Jagsonpal Pharmaceuticals Limited stock symbol ?

Jagsonpal Pharmaceuticals Limited is a IN stock and trading under the symbol JAGSNPHARM.NS

What is Jagsonpal Pharmaceuticals Limited stock quote today ?

Jagsonpal Pharmaceuticals Limited stock price is $252.43 today.

Is Jagsonpal Pharmaceuticals Limited stock public?

Yes, Jagsonpal Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
TL0.DE
VTSAX
ABEA.DE
MSFT
BRK-A
Top Correlated ETFs
EXXW.DE
LCPE.L
VERX.L
EDIV.L
VEUR.L
Top Correlated Stocks
603456.SS
000990.SZ
000800.SZ
002493.SZ
600216.SS
Similar Market Cap
SKBNK.IS
LW
XMHQ
CIBR
7271.T

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 42.44K
  • Market Capitalization 7.73B
  • Employee 940
  • CEO Mr. Manish Gupta
  • Headquarters New Delhi,IN
  • IPO Date 2002-07-01
  • Website https://www.jagsonpal.com

Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.